<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>兴证医药健康 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-09T20:32:31+08:00</updated>
  <subtitle>兴业证券医药生物小组最新观点、研究成果展示与交流平台</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>医药恢复高增长，未来跟随政策变化选股——兴证医药2020年11月投资月报</title>
    <updated>2020-11-04T11:06:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/uAn5M13GFsrGW_6HC-PynA</id>
    <link href="https://mp.weixin.qq.com/s/uAn5M13GFsrGW_6HC-PynA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>从瑞德西韦销售数据看新冠治疗市场--兴证海外医药周报(2020.10.27-10.30)</title>
    <updated>2020-11-04T11:06:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/pynPghRZO3SM2aDai4_EKA</id>
    <link href="https://mp.weixin.qq.com/s/pynPghRZO3SM2aDai4_EKA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>疫情影响逐渐消退，关注高成长龙头+细分冠军--医药生物上市公司2020年三季报小结</title>
    <updated>2020-11-03T00:01:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/_y04dD8oOQyancC8oX-ipg</id>
    <link href="https://mp.weixin.qq.com/s/_y04dD8oOQyancC8oX-ipg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【兴证医药】公募基金2020Q3医药持仓分析</title>
    <updated>2020-11-02T16:08:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/hKTKnc4rgD6k7F2EvFNDAg</id>
    <link href="https://mp.weixin.qq.com/s/hKTKnc4rgD6k7F2EvFNDAg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医院迈向精细化管理时代后的投资策略 --医药行业周报（2020.10.19-2020.10.23）</title>
    <updated>2020-10-27T09:46:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-27:/s/NKtf9MfyRiJkUFCFYsnKhw</id>
    <link href="https://mp.weixin.qq.com/s/NKtf9MfyRiJkUFCFYsnKhw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>支架集采方案公布，“进口替代+自主创新”之路加速开启 --医药行业周报（2020.10.12-2020.10.16）</title>
    <updated>2020-10-21T13:10:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-21:/s/M6tVPI1zJ2HT5tPwgGn91Q</id>
    <link href="https://mp.weixin.qq.com/s/M6tVPI1zJ2HT5tPwgGn91Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【行业跟踪】CRISPR技术及应用前景</title>
    <updated>2020-10-20T13:18:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-20:/s/jSS6J2TflCljiqOLktFvrQ</id>
    <link href="https://mp.weixin.qq.com/s/jSS6J2TflCljiqOLktFvrQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>冠脉支架全国集采方案出台，高值耗材集采时代正式来临</title>
    <updated>2020-10-19T13:02:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-19:/s/6bmlJpds8i0fNWBuMZVKmg</id>
    <link href="https://mp.weixin.qq.com/s/6bmlJpds8i0fNWBuMZVKmg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>科创板生物医药投资手册第34期—兴证医药科创板生物医药投资定期报告（2020.09.28-2020.10.11)</title>
    <updated>2020-10-16T23:28:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-16:/s/jZrIdrJ-S935CQOm7oeChA</id>
    <link href="https://mp.weixin.qq.com/s/jZrIdrJ-S935CQOm7oeChA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>关注三季报高增长板块：服务板块-10月投资月报</title>
    <updated>2020-10-11T17:29:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-11:/s/cXMvYh1qhF6G7L48n5dQzg</id>
    <link href="https://mp.weixin.qq.com/s/cXMvYh1qhF6G7L48n5dQzg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2020Q3业绩前瞻】Q3医药各子板块恢复显著，细分龙头增速较快</title>
    <updated>2020-10-08T14:50:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-08:/s/u6UnKTnD5JZcP4LyfjnDrA</id>
    <link href="https://mp.weixin.qq.com/s/u6UnKTnD5JZcP4LyfjnDrA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>